News | July 08, 2008

Summit Doppler Announces the Seated ABI for the Diagnosis of Peripheral Arterial Disease

July 9, 2008 - Summit Doppler Systems this week introduced a significant upgrade to the Vista AVS, a full-featured arterial physiologic exam system, which allows clinicians to perform the ankle brachial index (ABI) exam for the diagnosis of peripheral arterial disease (PAD) in the seated position.

The ABI exam, which compares systolic blood pressures obtained at the ankles and arms, was traditionally performed with the patient in the supine position to prevent error from hydrostatic pressure. This position requirement made the exam difficult for patients with disabilities or mobility impairments. Recent studies have shown these patients have reduced access to many diagnostic exams. The new Vista AVS reportedly calculates ABI values for seated patients by compensating for the effects of gravity on the lower extremity pressures.
Along with the ability to perform the seated ABI using hydrostatic pressure correction, the company said its new Vista AVS allows clinicians to customize segmental studies by selecting the number and location of arterial sites. While the ABI exam is performed as the initial test to diagnose PAD, segmental studies are performed on patients with PAD to localize the occlusion in the lower limbs.

PAD affects 8 to 12 million people in the U.S. every year. It is characterized by the narrowing of the arteries in the legs caused by plaque build-up, also known as atherosclerosis. Early detection can prevent further cardiovascular events, such as heart attack, stroke and death. Awareness of PAD and its diagnosis and treatment are rapidly increasing. Better equipment and reimbursement for the diagnosis is making the exam cost effective for office-based medical practices.
The Vista AVS, first released in 2007, was designed by Summit Doppler to make the ABI and other arterial exams faster, easier, and more affordable.

For more information: www.summitdoppler.com


Related Content

News | Ultrasound Imaging

Aug. 22, 2024 – AISAP has announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for ...

Home August 27, 2024
Home
News | Ultrasound Imaging

April 3, 2024 — GE HealthCare announced the launch of Caption AI artificial intelligence (AI)-driven software for rapid ...

Home April 03, 2024
Home
News | Ultrasound Imaging

April 3, 2024 — - Eko Health, a pioneer in applying artificial intelligence (AI) for early detection of heart and lung ...

Home April 03, 2024
Home
News | Ultrasound Imaging

September 15, 2023 — Contrast enhanced ultrasound (CEUS) is underutilized in the United States, and reduced access to ...

Home September 15, 2023
Home
News | Ultrasound Imaging

August 3, 2023 — Butterfly Network, Inc. a digital health company transforming care through the power of portable ...

Home August 03, 2023
Home
News | Ultrasound Imaging

May 11, 2023 — Esaote, a leading manufacturers of medical diagnostic systems (specifically, ultrasound, dedicated MRI ...

Home May 11, 2023
Home
News | Ultrasound Imaging

April 24, 2023 — Butterfly Network, Inc., a digital health company transforming care through the power of handheld ...

Home April 24, 2023
Home
News | Ultrasound Imaging

January 30, 2023 — Heart disease is the leading cause of death worldwide. In the U.S., it is estimated that someone dies ...

Home January 30, 2023
Home
News | Ultrasound Imaging

December 8, 2022 — Butterfly Network, Inc., a digital health company transforming care with handheld, whole-body ...

Home December 08, 2022
Home
News | Ultrasound Imaging

August 10, 2022 — Butterfly Network, Inc., a digital health company transforming care with handheld, whole-body ...

Home August 10, 2022
Home
Subscribe Now